Effects of Large-Pore Hemofiltration in a Swine Model of Fulminant Hepatic Failure.DETRY, Olivier ; JANSSEN, Nathalie ; CHERAMY-BIEN, Jean-Paul et alin Artificial Organs (2012), 36(11), 981-987 Among the different potential mechanisms that could lead to brain edema and intracranial hypertension in fulminant hepatic failure (FHF), the inflammatory hypothesis implies that systemic inflammation ... [more ▼] Among the different potential mechanisms that could lead to brain edema and intracranial hypertension in fulminant hepatic failure (FHF), the inflammatory hypothesis implies that systemic inflammation might be in part responsible for an increase in cerebral blood flow (CBF) and brain water content. In this study, the authors used a validated ischemic FHF swine model to evaluate the effects of 80 kDa large-pore membrane hemofiltration (LPHF) on intracranial pressure (ICP) and CBF, in relation with the clearance of proinflammatory cytokines and blood liver tests, as primary end points. Fifteen pigs were randomized into one of three groups: SHAM, FHF, and FHF + LPHF. All experiments lasted 6 h. In the FHF groups, liver failure was induced by liver ischemia. After 2 h, the FHF + LPHF group underwent 4 h of a zero-balance continuous veno-venous hemofiltration using a 0.7-m(2) , large-pore (78 A) membrane with a cutoff of 80 kDa. ICP, CBF, mean arterial pressure, central venous pressure, and heart rate were continuously monitored and recorded. Arterial aspartate aminotransferase, total bilirubin, creatinine, international normalized ratio, glucose, lactate and serum cytokines interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha were measured at T0, T120, and T360. Over the 6 h following liver ischemia, the FHF group developed a significant increase in ICP. This ICP rise was not observed in the SHAM group and was attenuated in the FHF + LDHF group. However, the ICP levels were not different at T360 in the FHF + LDHF group compared to the FHF group. No significant effect of LPHF on liver tests or levels of proinflammatory cytokines could be demonstrated. In this model, 80 kDa LPHF was not efficient to control FHF intracranial hypertension and to decrease serum cytokine levels. [less ▲] Detailed reference viewed: 20 (2 ULg)![]() Vitamin D Status, calcium and protein metabolism in dogs fed bone and raw food (BARF) or commercial pet food; Krafft, Emilie ; Roels, Elodie et alPoster (2012, October 19) Detailed reference viewed: 28 (1 ULg) Demystifying ethnic/sex differences in kidney function: is the difference in (estimating) glomerular filtration rate or in serum creatinine concentration?; ; DELANAYE, Pierre et alin Clinica Chimica Acta (2012), 413(19-20), 1612-17 BACKGROUND: The recent evaluation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation for estimating the glomerular filtration rate (GFR) in multiple ethnicities has raised the ... [more ▼] BACKGROUND: The recent evaluation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation for estimating the glomerular filtration rate (GFR) in multiple ethnicities has raised the question on how well this equation performs for African-American and Asian subjects. There is no doubt that serum creatinine (Scr) concentration differs between ethnicities and sexes. We show that creatinine-based equations for white populations may be inaccurate for estimating GFR in other ethnic/gender groups, especially in populations from Asia. METHODS: This study presents a mathematical analysis of the CKD-EPI-equation complemented with a literature review of median and reference values for IDMS-standardized Scr-concentrations for multiple ethnicities. RESULTS: The study shows that at equal eGFR-CKD-EPI-values, the ratio of Scr between females and males equals 0.79 and between other ethnicities/sexes and white males is constant too. From this information, it is possible to calculate mean Scr-values that correspond very well with literature values directly obtained from Scr-distributions in healthy white males and females and in black males, but the discrepancy is larger for other populations. CONCLUSIONS: Our results confirm the criticism that has been raised for using the CKD-EPI-equation for these ethnicities. An alternative eGFR-model is proposed based on a population-normalized Scr that needs further validation. [less ▲] Detailed reference viewed: 20 (0 ULg) Distinctive aspects of laboratory testing to evaluate mineral and bone metabolism in patients with chronic kidney disease; ; CAVALIER, Etienne ![]() in Joint Bone Spine (2012), 79(suppl 2), 99-103 Detailed reference viewed: 11 (0 ULg) Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde.LE GOFF, Caroline ; Kaux, Jean-François ; et alin Immuno-Analyse & Biologie Spécialisée [=IBS] (2012), 27(5), 237-243 The aim of our study was to compare reference values for these FA with data obtained in a population of acute myocardial infarction patients. We performed the quantification of different FA by gas ... [more ▼] The aim of our study was to compare reference values for these FA with data obtained in a population of acute myocardial infarction patients. We performed the quantification of different FA by gas chromatography associated with flame ionization detector ( FA determination is a new tool we are able to use and to process in our laboratory which can help the clinician to screen patients with the highest cardiovascular risks because of the implication of FA in the etiopathogeny of atherosclerosis. [less ▲] Detailed reference viewed: 28 (6 ULg) The thyrogastric syndrome : an under diagnosed etiology for acquired gastric neuroendocrine tumors. A case reportVALDES SOCIN, Hernan Gonzalo ; LOLY, Jean ; GAST, Pierrette et alin Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia (2012, September) Detailed reference viewed: 33 (8 ULg) analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration RateHAMDI, Eya ; DELANAYE, Pierre ; LUTTERI, Laurence et alPoster (2012, July 18) Detailed reference viewed: 19 (5 ULg) Analytical performance of two Thyroglobulin assays in the low range: impact on clinical decisionsCAVALIER, Etienne ![]() Poster (2012, July 18) Detailed reference viewed: 16 (5 ULg) Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native SamplesLE GOFF, Caroline ; PEETERS, Stéphanie ; CRINE, Yannick et alPoster (2012, July 17) Detailed reference viewed: 24 (6 ULg) Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500LE GOFF, Caroline ; PEETERS, Stéphanie ; CRINE, Yannick et alPoster (2012, July 17) Detailed reference viewed: 24 (1 ULg) Evaluation of the Liaison 25-OH Vitamin D Total assay on the new Liaison XL analyserCAVALIER, Etienne ![]() Conference (2012, July 17) Detailed reference viewed: 22 (3 ULg) Comparison of two automated 3rd generation PTH assays in different clinical populationsCAVALIER, Etienne ; CARLISI, Ignazia ; ROUSSELLE, Olivier et alPoster (2012, July 17) Detailed reference viewed: 28 (6 ULg) Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP)CAVALIER, Etienne ; CARLISI, Ignazia ; MEURISSE, Angélique et alPoster (2012, July 17) Detailed reference viewed: 13 (3 ULg) Variability of Different Markers of Bone mineral Metabolism in Hemodialysis PAtients: Implication on the Evaluation of the Critical Difference between two MeasurementsCAVALIER, Etienne ; DELANAYE, Pierre ; CARLISI, Ignazia et alPoster (2012, July 17) Detailed reference viewed: 20 (1 ULg) Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated ImmunoassayCAVALIER, Etienne ; CARLISI, Ignazia ; FERRANTE, Nunzio et alPoster (2012, July 17) Detailed reference viewed: 21 (1 ULg) Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XLCAVALIER, Etienne ; CARLISI, Ignazia ; FERRANTE, Nunzio et alPoster (2012, July 17) Detailed reference viewed: 34 (5 ULg) Evaluation of Sclerostin levels in patients suffering from Chronic Kidney DiseasesCAVALIER, Etienne ; CARLISI, Ignazia ; FERRANTE, Nunzio et alPoster (2012, July 17) Detailed reference viewed: 17 (1 ULg) Normal reference values for glomerular filtration rate: what do we really know?DELANAYE, Pierre ; ; et alin Nephrology Dialysis Transplantation (2012), 27(7), 2664-72 In nephrology, chronic kidney disease is defined by both proteinuria and measurement of glomerular filtration rate (GFR). This article focuses on GFR and different ways to define its normal reference ... [more ▼] In nephrology, chronic kidney disease is defined by both proteinuria and measurement of glomerular filtration rate (GFR). This article focuses on GFR and different ways to define its normal reference values. In this context, we compare two perspectives: first the reference values defined by measuring GFR in normal individuals (the 'classical way') and secondly a fixed cut-off value at 60 mL/min/1.73 m(2) according to the associated mortality risk (the 'prognostic way'). Following the classical way, we can assert that normal GFR values are largely over 60 mL/min/1.73 m(2) in healthy subjects, at least before the age of 70 years. However, we know that GFR physiologically decreases with age, and in adults older than 70 years, values below 60 mL/min/1.73 m(2) could be considered normal. Following the 'prognostic way', the fixed cut-off of 60 mL/min/1.73 m(2) has been retained in the K-DIGO guidelines. However, we challenge this concept and the fact that the variable 'age' is poorly taken into account in these data. There is an obvious discrepancy between the reference values defined either by the 'classical way' or by the 'prognostic way' which we think could be largely reduced, if age was better taken into consideration in these definitions. [less ▲] Detailed reference viewed: 15 (0 ULg) PTH in Chronic Kidney Disease - What do the KDIGO Guidelines ChangeCAVALIER, Etienne ![]() Conference (2012, June 14) Detailed reference viewed: 13 (0 ULg) Mise au point sur les méthodes de dosage de la Vitamine D et de la ParathormoneCAVALIER, Etienne ![]() Conference (2012, June 09) Detailed reference viewed: 6 (0 ULg) |
||